Interestingly enough, in 6-OHDA rats, the dual GLP-1/GIP agonist (DA5-CH), in addition to promoting the survival of dopaminergic neurons, was able to reduce the levels of monomer and oligomers of -synuclein, thus providing a wider neuroprotective effect [53]
Fine lines appear softer 3
Left panel (Mechanism of Action & Pharmacodynamics) : Imipramine inhibits the serotonin transporter (SERT) and norepinephrine transporter (NET), resulting in increased synaptic concentrations of serotonin and norepinephrine (dual monoamine reuptake inhibition)
Amounts of studies have demonstrated that the level of MTHFR polymorphism in C677T locus is associated with the risk of schizophrenia
GLP-1 medications are not approved for treating alcohol use disorder, and any effects on drinking behaviour are incidental rather than therapeutic
Regulatory developments in this space are ongoing